Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0600
-0.0020 (-3.23%)
Jul 27, 2026, 3:22 PM EST
PVCT Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -5.58 | -5.43 | -4.73 | -3.1 | -3.55 | -5.54 |
Depreciation & Amortization | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Stock-Based Compensation | 1.23 | 1.24 | 1.28 | 0 | 0 | 0.02 |
Other Operating Activities | -0.02 | -0.03 | 0.02 | 0.05 | 0.05 | 0.02 |
Change in Accounts Receivable | - | - | 0 | -0 | 0 | - |
Change in Accounts Payable | 0.07 | -0.39 | -0.57 | -0.42 | 0.81 | 0.33 |
Change in Unearned Revenue | -0.06 | -0.34 | -0.62 | -0.56 | -0.99 | 2.5 |
Change in Other Net Operating Assets | 1.76 | 1.62 | 1.33 | 1.45 | 0.62 | 1.64 |
Operating Cash Flow | -2.59 | -3.33 | -3.28 | -2.57 | -3.04 | -1.01 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | 1.63 | 3.16 |
Long-Term Debt Issued | - | 2.51 | 2.85 | 2.48 | - | - |
Total Debt Issued | 2.39 | 2.51 | 2.85 | 2.48 | 1.63 | 3.16 |
Short-Term Debt Repaid | - | -0.27 | -0.31 | -0.28 | -0.26 | -0.25 |
Long-Term Debt Repaid | - | - | -0.1 | - | - | - |
Total Debt Repaid | -0.27 | -0.27 | -0.41 | -0.28 | -0.26 | -0.25 |
Net Debt Issued (Repaid) | 2.12 | 2.24 | 2.45 | 2.19 | 1.37 | 2.91 |
Issuance of Common Stock | - | - | - | - | - | 0.96 |
Other Financing Activities | 0.23 | 0.85 | 0.3 | - | - | 0.15 |
Financing Cash Flow | 2.34 | 3.09 | 2.75 | 2.19 | 1.37 | 4.02 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0 | 0 | -0 | -0.02 | -0 | -0 |
Net Cash Flow | -0.25 | -0.24 | -0.54 | -0.4 | -1.68 | 3.01 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.59 | -3.33 | -3.28 | -2.57 | -3.04 | -1.01 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -4506.11% | -989.56% | -532.15% | -461.17% | -307.52% | - |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 |
Levered Free Cash Flow | -0.61 | -1.34 | -2.93 | -1.16 | -0.88 | -6.94 |
Unlevered Free Cash Flow | -0.48 | -1.2 | -2.78 | -1.03 | -0.77 | -6.34 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0 | 0 | 0.01 | - | - | - |
Change in Working Capital | 1.78 | 0.89 | 0.14 | 0.47 | 0.45 | 4.47 |